What antibiotics are recommended for treating acute diverticulitis?

Antibiotic Management for Acute Diverticulitis

For immunocompetent adults with uncomplicated acute diverticulitis who can tolerate oral intake, antibiotics are not routinely required—supportive care alone is sufficient. 1

Risk Stratification: Who Needs Antibiotics?

Low-Risk Patients: Antibiotics NOT Required

• Immunocompetent adults with uncomplicated diverticulitis (no abscess, perforation, obstruction, or fistula) who can tolerate oral intake do not need routine antibiotics. 1
• Supportive care with pain management (acetaminophen) and clear liquid diet yields comparable outcomes to antibiotic therapy for treatment failure, complications, surgery rates, and recurrence at 12–24 months. 1
• This approach is supported by low-certainty evidence but represents current guideline consensus. 1

High-Risk Patients: Antibiotics ARE Required

Antibiotics are mandatory when any of these features are present: 1, 2

• Immunocompromised status (corticosteroids, chemotherapy, transplant recipients)
• ASA physical status III or IV
• Symptom duration > 5 days before presentation
• Vomiting or inability to tolerate oral intake
• C-reactive protein > 140 mg/L
• White blood cell count > 15 × 10⁹/L
• Fluid collection on CT imaging
• Length of inflamed colon ≥ 86 mm on CT
• Complicated diverticulitis (abscess, perforation, peritonitis)
• Age > 80 years 2
• Pregnancy 2
• Chronic medical conditions (cirrhosis, chronic kidney disease, heart failure, poorly controlled diabetes) 2

Recommended Antibiotic Regimens

Outpatient Oral Therapy (Uncomplicated Disease)

When antibiotics are indicated and the patient can tolerate oral intake, use a 4–7 day course of: 1

First-line options (equally effective):

• Amoxicillin-clavulanate 875 mg/125 mg orally twice daily 1, 2, 3
• Ciprofloxacin 500–750 mg orally twice daily PLUS metronidazole 500 mg orally three times daily 1, 2, 3

Alternative for β-lactam allergy:

• Levofloxacin 750 mg orally once daily PLUS metronidazole 500 mg orally three times daily 4
• Moxifloxacin 400 mg orally once daily (single-agent option with gram-negative and anaerobic coverage) 4
• Cefalexin PLUS metronidazole 2

Important caveat: Amoxicillin-clavulanate may reduce fluoroquinolone-related harms (including C. difficile infection risk) without adversely affecting diverticulitis outcomes. 3 The FDA advises reserving fluoroquinolones for conditions with no alternative options. 3

Inpatient Intravenous Therapy (Complicated Disease or Unable to Tolerate Oral)

For patients requiring hospitalization: 2

• Ceftriaxone PLUS metronidazole
• Cefuroxime PLUS metronidazole
• Ampicillin-sulbactam
• Piperacillin-tazobactam (for perforated diverticulitis or severe complicated disease)

Transition from IV to Oral Therapy

Switch to oral antibiotics when the patient demonstrates: 4

• Afebrile for ≥ 24 hours
• Tolerating oral intake
• Decreasing leukocytosis
• Improving abdominal examination

Preferred oral step-down regimen: Amoxicillin-clavulanate 875 mg/125 mg orally twice daily 4

Total duration (IV + oral): 14 days for perforated or complicated diverticulitis 4

Special Populations

Immunocompromised Patients

• Mandatory antibiotics regardless of disease severity 1
• Broader-spectrum coverage for 10–14 days 1, 4
• Lower threshold for CT imaging 1
• Colorectal surgery consultation after recovery to discuss elective resection 1

Resistant Organisms

• When cultures identify ESBL-producing organisms or other resistant pathogens, select antibiotics based on susceptibility results rather than empiric regimens 4

Common Pitfalls to Avoid

• Over-prescribing antibiotics in low-risk uncomplicated diverticulitis: Most immunocompetent patients with mild disease do not benefit from antibiotics and are exposed to unnecessary risks including C. difficile infection. 1, 3, 5
• Fluoroquinolone overuse: Amoxicillin-clavulanate is equally effective and may have a better safety profile, particularly regarding C. difficile risk in older adults. 3
• Inadequate risk stratification: Failing to identify high-risk features (immunosuppression, severe inflammatory markers, imaging findings) can lead to treatment failure. 1
• Premature discharge on oral antibiotics: Ensure clinical improvement criteria are met before transitioning from IV to oral therapy in complicated cases. 4